Decamethonium bromide
featured

    WARNING: This product is for research use only, not for human or veterinary use.

MedKoo CAT#: 317585

CAS#: 541-22-0

Description: Decamethonium (Syncurine) is a depolarizing muscle relaxant or neuromuscular blocking agent, and is used in anesthesia to induce paralysis. Decamethonium, which has a short action time, is similar to acetylcholine and acts as a partial agonist of the nicotinic acetylcholine receptor. In the motor endplate, it causes depolarization, preventing further effects to the normal release of acetylcholine from the presynaptic terminal, and therefore preventing the neural stimulus from affecting the muscle.


Chemical Structure

img
Decamethonium bromide
CAS# 541-22-0

Theoretical Analysis

MedKoo Cat#: 317585
Name: Decamethonium bromide
CAS#: 541-22-0
Chemical Formula: C16H38Br2N2
Exact Mass: 0.00
Molecular Weight: 418.302
Elemental Analysis: C, 45.94; H, 9.16; Br, 38.20; N, 6.70

Price and Availability

Size Price Availability Quantity
5g USD 300 2 Weeks
10g USD 550 2 Weeks
Bulk inquiry

Synonym: Decamethonium; Decamethonum; Syncurine; DECAMETHONIUM ION; Lopac-D-1260; (DM)Br2

IUPAC/Chemical Name: trimethyl-[10-(trimethylazaniumyl)decyl]azanium bromide

InChi Key: HLXQFVXURMXRPU-UHFFFAOYSA-L

InChi Code: InChI=1S/C16H38N2.2BrH/c1-17(2,3)15-13-11-9-7-8-10-12-14-16-18(4,5)6;;/h7-16H2,1-6H3;2*1H/q+2;;/p-2

SMILES Code: C[N+](CCCCCCCCCC[N+](C)(C)C)(C)C.[Br-].[Br-]

Appearance: Solid powder

Purity: >98% (or refer to the Certificate of Analysis)

Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility: Soluble in DMSO, not in water

Shelf Life: >2 years if stored properly

Drug Formulation: This drug may be formulated in DMSO

Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code: 2934.99.9001

More Info:

Biological target:
In vitro activity:
In vivo activity:

Preparing Stock Solutions

The following data is based on the product molecular weight 418.30 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
Formulation protocol:
In vitro protocol:
In vivo protocol:

Molarity Calculator

Calculate the mass, volume, or concentration required for a solution.
=
x
x
g/mol

*When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and SDS / CoA (available online).

Reconstitution Calculator

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

=
÷

Dilution Calculator

Calculate the dilution required to prepare a stock solution.
x
=
x

1: Brown TC. Aspects of depolarizing neuromuscular blockers: decamethonium and suxamethonium. Paediatr Anaesth. 2013 Sep;23(9):868-70. doi: 10.1111/pan.12122. Epub 2013 Feb 11. PubMed PMID: 23398375.

2: Poulsen H, Hougs W. The effect of some curarizing drugs in unanaesthetized man. I. d-Tubocurarine chloride, gallamonium iodide, decamethonium iodide, succinylcholine iodide and its bis-monoethyl-substituted derivative in single or repeated doses. Acta Anaesth. Scandinav. 1957, 1, 15-39. Acta Anaesthesiol Scand. 2007 Sep;51(8):1018-42; discussion 1043. PubMed PMID: 17697296.

3: Ball C, Westhorpe R. Muscle relaxants--decamethonium. Anaesth Intensive Care. 2005 Dec;33(6):709. PubMed PMID: 16398373.

4: Macharia R, Patel K, Otto WR, McKinnell IW, Christ B. Decamethonium bromide-mediated inhibition of embryonic muscle development. Anat Embryol (Berl). 2004 Apr;208(1):75-85. Epub 2004 Mar 3. PubMed PMID: 14997390.

5: Lee C, Jones T. Molecular conformation-activity relationship of decamethonium congeners. Br J Anaesth. 2002 May;88(5):692-9. PubMed PMID: 12067008.

6: Redai I, Richards KM, England AJ, Feldman SA. Interaction of decamethonium with hexamethonium or vecuronium in the rat: an isobolographic analysis. Anesth Analg. 1995 Oct;81(4):768-72. PubMed PMID: 7574008.

7: Gu Y, Lee H, Hudson RA. Bis-catechol-substituted redox-reactive analogues of hexamethonium and decamethonium: stimulated affinity-dependent reactivity through iron peroxide catalysis. J Med Chem. 1994 Dec 9;37(25):4417-20. PubMed PMID: 7996555.

8: Effraim KD, Ahmad K. Short communication on erythrocyte membrane stabilization by decamethonium and succinylcholine. Cent Afr J Med. 1994 May;40(5):134-6. PubMed PMID: 7954726.

9: Campkin NT, Hood JR, Feldman SA. Resistance to decamethonium neuromuscular block after prior administration of vecuronium. Anesth Analg. 1993 Jul;77(1):78-80. PubMed PMID: 8100407.

10: Feldman S, Fauvel N. Potentiation and antagonism of vecuronium by decamethonium. Anesth Analg. 1993 Mar;76(3):631-4. PubMed PMID: 8095780.